Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

Oliver Ottmann, Giuseppe Saglio, Jane F. Apperley, Christopher Arthur, Eduardo Bullorsky, Aude Charbonnier, John F. Dipersio, Hagop Kantarjian, Hanna Jean Khoury, Dong Wook Kim, Diane Healey, Lewis Strauss, Jorge E. Cortes

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib'. Together they form a unique fingerprint.